Q59MJ1 AF NFT

multidrug resistance regulator 2

MOLNFT AF v1 smart contract in GenesisL1 blockchain: 
0xBf7491af3407816DFa88a5EA4c82e8A2B1D721eD
IPFS of NFT metadata: 
bafybeiar33jd2e2zo2atjletklezgt5zhtm4vbhalq6a6vhkxtpavxmyze/metadata.json
IPFS of structure file: 
bafybeigu7hmasw2ze4gv6jkezku2pusgjoqfs6uv3hdsj5sunhncegc6m4/AF-Q59MJ1-F1-model_v2.pdb
First NFT owner address (eip-55): 
0x0723bE2dC4382812cA78809C938FA943Db470CDc
First NFT owner address (bech32): 
genesis1qu3mutwy8q5p9jncszwf8rafg0d5wrxu0w7uw0
Current NFT ID #244244 owner (web3):

First owner GALLERY | EVM EXPLORER | COSMOS EXPLORER

MOLNFT AF v1_w

NFT id:
244244
Accession (UniProt):
Q59MJ1
Name::
multidrug resistance regulator 2
Experimental Method:
Predicted structure
Sequence source:
CANDIDA ALBICANS (STRAIN SC5314 / ATCC MYA-2876)

NFT data

MolNFT AF v1 is an AlphaFold database of AI predicted Swiss-Prot protein sequences preserved as regular ERC-721 NFT tokens on GenesisL1 blockchain for public free use, research and entertainment:

https://alphafold.ebi.ac.uk/
Jumper, J., Evans, R., Pritzel, A. et al. Highly accurate protein structure prediction with AlphaFold. 
Nature 596, 583–589 (2021). https://doi.org/10.1038/s41586-021-03819-2

MOLNFT Q59MJ1 research and analysis (ICN3D with VR)

FASTA sequences

>sp|Q59MJ1|MRR2_CANAL multidrug resistance regulator 2 OS=Candida albicans (strain SC5314 / ATCC MYA-2876) OX=237561 GN=MRR2 PE=3 SV=1 MTKRDRTIYSCDACRSRKIKCNRQTPCASCHKSKRDCVYTVSRQRDAQITNRKLDKKTYHQISAIEKKISALEGKKGLLQVETINFNKSFTDQTPLVELQSLFPYLLLSKQDPGCVLVRHHCHHLLEKDPRYFEYSQLLADLSLTKRHHLTARAKALLGEAYIPSPQEGHTIDQLKHVLSLNPNFRFAGNFADPLTSFFSLIPPAWANKQLVDTFFQHIYPVIPIIDETDFNTSINRVLGPQIDGHYINSFPSIGSADDLPFLALFLLVLRISYMYTPGACPVSYDTLRAAETIMKEFDITKTHSLTALQAEIMLRFYKIVAPESYTQSNYVQVSVGVLIQNCYSLALHRDPEYIGEHNPKQQHLRRKIWHLLLRMEVIDSAIFQTILSSNPDASDTKLPQLIDQAPPMEQSIVKHIWRSTDLFVSLRKLVEINSKTSEDTPLETVLELLVEVETKLQAFLATIDSEASTVFYNDLVIFSVNFLLVYMYYSLYLFKGPTPLGNKYLLKSAQILFVDLARTRSTSLFLAYFNLNYIHLVLMITNFLRMRVDCIIHRHLRAQDSSVQDLQCCRYFLKIIFFSHVKELGNYSSSHKYAWQMRKVYLTLAKIMERSSDVLISNDPELVKSAAVDIPVKEINKLLEQYINFKGFTPTTLFDPTDNELIDEMQHENLWNAMENIEYSEKVYSGWIDAIKNVPSNWDWDYWDFLKIS